SYnAbs enters Chinese market!

SynAbs is proud to announce strategic deal with successful company Dakewe Biotech Co. Dakewe already distributes major references in the field of monoclonal antibodies and will consequently extends its catalogue with unique mAbs references from SynAbs. Under the terms of the agreement, Dakewe will have access to unique portfolio of rats and guinea pigs mAbs to address China territories needs in R&D and IVD fields.